Healthcare major Apollo Hospitals Enterprises today reported a 36.02% rise in net profit to Rs 69.74 crore for the
quarter ended June 30, 2012, on account of robust performance of healthcare services and pharmacy segments.
The company had posted a net profit of Rs 51.27 crore for the corresponding period previous fiscal, Apollo Hospitals Enterprises said in a filing to BSE.
Net sales of the company stood at Rs 777.39 crore for the quarter under consideration as against Rs 641.01 crore for the same period year ago.
During the quarter under consideration net sales from healthcare sector rose to Rs 529.90 crore from Rs 451.42 crore for the corresponding quarter last fiscal, the company said.
Pharmacy sales grew to Rs 247.66 crore for quarter ended June 30, 2012 from Rs 189.76 crore for the same period last fiscal, it added.
During the quarter, the company alloted 13,81,619 equity shares of face value of Rs 5 each to International Finance Corporation, Washington at a
price of Rs 302.50 per share upon conversion of balance Foreign Currency Convertible Bond (FCCB) loan amount of USD 7.5 million, Apollo Hospitals said.
Consequent to the allotment, the paid up equity share capital increased to Rs 67.92 crore from Rs 67.23 crore, it added.
Outstanding global depositary receipts (GDRs) as on June 30, 2012 were 5,295,469 constituting 3.90% of the total number of the shares of
the company, Apollo Hospitals said.
Shares of Apollo Hospitals Enterprises were today trading at Rs 618.70 per scrip in the afternoon trade on BSE, up 1% from its previous close.